Paul Tudor Jones's NUVB Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 267,032 shares of Nuvation Bio Inc. (NUVB) worth $1.5 M, representing 0.00% of the portfolio. First purchased in 2026-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in NUVB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 267,032 shares. Largest reduction occurred in Q2 2026, reducing 177,260 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Nuvation Bio (NUVB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvation Bio (NUVB) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +267,032 | New Buy | 267,032 | $5.60 |
| Q2 2026 | -177,260 | Sold Out | 0 | $0.00 |
| Q1 2026 | +177,260 | New Buy | 177,260 | $4.29 |
Paul Tudor Jones's Nuvation Bio Investment FAQs
Paul Tudor Jones first purchased Nuvation Bio Inc. (NUVB) in Q1 2026, acquiring 177,260 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Nuvation Bio Inc. (NUVB) for 3 quarters since Q1 2026.
Paul Tudor Jones's largest addition to Nuvation Bio Inc. (NUVB) was in Q3 2026, adding 267,032 shares worth $1.5 M.
According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 267,032 shares of Nuvation Bio Inc. (NUVB), valued at approximately $1.5 M.
As of the Q3 2026 filing, Nuvation Bio Inc. (NUVB) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Nuvation Bio Inc. (NUVB) was 267,032 shares, as reported at the end of Q3 2026.